Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:28:14.588Z.
Calculation as of: 2026-10-06T18:28:14.588Z.
Quote observation: 2026-10-06T18:25:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 033b533528001a3499036996a5838431eca9b2abd512acbebbb4929ff412c5bb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Sana Biotechnology, Inc.
Market Cap
$780.61M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$782.66M
Free Cash Flow Yield
N/A
TTM Avg
1.71%
3Y Avg
1.71%
5Y Avg
1.71%
Market Cap
$778.22M
Free Cash Flow Yield
N/A
TTM Avg
6.80%
3Y Avg
7.30%
5Y Avg
6.57%
Market Cap
$785.58M
Free Cash Flow Yield
12.43%
TTM Avg
14.50%
3Y Avg
12.95%
5Y Avg
8.98%
Market Cap
$775.12M
Free Cash Flow Yield
N/A
TTM Avg
46.69%
3Y Avg
46.69%
5Y Avg
28.31%
Market Cap
$794.92M
Free Cash Flow Yield
N/A
TTM Avg
0.32%
3Y Avg
2.22%
5Y Avg
3.37%
Market Cap
$765.90M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$759.16M
Free Cash Flow Yield
6.96%
TTM Avg
7.62%
3Y Avg
7.21%
5Y Avg
5.53%
Market Cap
$802.43M
Free Cash Flow Yield
10.90%
TTM Avg
10.11%
3Y Avg
10.17%
5Y Avg
7.95%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | $780.61M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $782.66M | N/A | 1.71% | 1.71% | 1.71% |
| Varex Imaging Corporation (VREX)vs › | $778.22M | N/A | 6.80% | 7.30% | 6.57% |
| AdaptHealth Corp. (AHCO)vs › | $785.58M | 12.43% | 14.50% | 12.95% | 8.98% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | N/A | 46.69% | 46.69% | 28.31% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $794.92M | N/A | 0.32% | 2.22% | 3.37% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $765.90M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $759.16M | 6.96% | 7.62% | 7.21% | 5.53% |
| InMode Ltd. (INMD)vs › | $802.43M | 10.90% | 10.11% | 10.17% | 7.95% |
| Jade Biosciences, Inc. (JBIO)vs › | $804.96M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
